Table 1.
Patient characteristics
| Mild COVID (n = 17) | Severe COVID (n = 13) | Healthy controls (n = 20) | |
|---|---|---|---|
| Age (median, IQR) | 47.4 (34.0; 57.0) | 61 (53.5; 69.5) | 35 (29.0;47.0) |
| Female | 7 | 1 | 14 |
| Days post‐symptom onset | 7 (10; 5.5) | 10 (8.5; 15) | |
| Concomitant antibiotic treatment | 0 | 6 | |
| Immunosuppressive treatment before COVID | 4 | 1 | |
| Dexamethasone | 0 | 12 | |
| Tocilizumab | 0 | 1 | |
| Remdesivir | 0 | 1 | |
| CRP mg/dL | n.a. | 116 (85.75; 188) | |
| WHO Ordinal scale 1 | 2 | ||
| WHO Ordinal scale 2 | 15 | ||
| WHO Ordinal scale 5 | 6 | ||
| WHO Ordinal scale 6 | 2 | ||
| WHO Ordinal scale 8 | 5 |